clinical trial · NCT06787560
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
Zhejiang University·early phase1·recruiting·n = 20
Bone Marrow Failure SyndromeCD7 CAR-T cells injectionAllo-HSCT
brief summary
A Clinical Study on the Safety and Effectiveness of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation for Non-malignant Blood and Immune System Diseases
started
Jan 31, 2025
primary completion
Jan 31, 2028
completion
Jan 31, 2028
last updated
Jan 22, 2025
detailed description
This is a single-arm, open-label clinical trial to evaluate the safety and efficacy of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation for Non-malignant Blood and Immune System Diseases. It is planned to enroll 12-20 participants in this trial.
official title
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation for Non-malignant Blood and Immune System Diseases
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol